RT Journal Article
SR Electronic
T1 1403 A bispecific antibody targeting PD1 and CD40 displays potent anti-tumor efficacy through two mechanisms: PD1 blockade and PD1-dependent CD40 agonism
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1561
OP A1561
DO 10.1136/jitc-2023-SITC2023.1403
VO 11
IS Suppl 1
A1 Zhang, Zhenqing
A1 Jia, Yunli
A1 Huang, Weifeng
A1 Wang, Chao
A1 Jiang, Wenchao
A1 Li, Zhiyuan
A1 Tsun, Andy
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1561.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.